Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001158 · ClinicalTrials.gov registry record
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
NCT00001158: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001158 is a clinical trial that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001158 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
Study Summary
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.
Trial Details
| Field | Value |
|---|---|
| Start Date | 1977-04 |
| Est. Completion | 2000-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001158
The ClinicalTrials.gov registry entry for NCT00001158 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001158 about?
NCT00001158 is a clinical study titled "Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System". The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be u...
What is the current status of trial NCT00001158?
This trial is currently completed. The study started on 1977-04. Estimated completion is 2000-03.
Who is sponsoring clinical trial NCT00001158?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.